Versa Vascular
Develops a transcatheter device for minimally invasive tricuspid valve repair
$42MSeries C
Role not disclosedLoading investors…
Activity from announced rounds
Develops a transcatheter device for minimally invasive tricuspid valve repair
Developing a nanoparticle platform for local dual-drug delivery during catheter-based vascular interventions
Develops thrombectomy systems for venous thromboembolism treatment
Pitching S3 Ventures? Send the deck from a free RoundOS data room and see which pages they read.
Create a free room